Gene Symbol | GSK3A |
---|---|
Entrez Gene | 2931 |
Alt Symbol | - |
Species | Human |
Gene Type | protein-coding |
Description | glycogen synthase kinase 3 alpha |
Other Description | GSK-3 alpha|glycogen synthase kinase-3 alpha|serine/threonine-protein kinase GSK3A |
Swissprots | O14959 P49840 |
Accessions | AAD11986 EAW57114 EAW57115 P49840 BC027984 AAH27984 BC051865 AAH51865 CR749620 CAH18414 D63424 BAA23608 DQ891014 ABM81940 DQ893329 ABM84255 DQ894195 ABM85121 DQ896624 ABM87623 L40027 AAA62432 NM_019884 NP_063937 |
Function | Constitutively active protein kinase that acts as a negative regulator in the hormonal control of glucose homeostasis, Wnt signaling and regulation of transcription factors and microtubules, by phosphorylating and inactivating glycogen synthase (GYS1 or GYS2), CTNNB1/beta-catenin, APC and AXIN1. Requires primed phosphorylation of the majority of its substrates. Contributes to insulin regulation of glycogen synthesis by phosphorylating and inhibiting GYS1 activity and hence glycogen synthesis. Regulates glycogen metabolism in liver, but not in muscle. May also mediate the development of insulin resistance by regulating activation of transcription factors. In Wnt signaling, regulates the level and transcriptional activity of nuclear CTNNB1/beta-catenin. Facilitates amyloid precursor protein (APP) processing and the generation of APP-derived amyloid plaques found in Alzheimer disease. May be involved in the regulation of replication in pancreatic beta-cells. Is necessary for the establish |
Top Pathways | Chemokine signaling pathway, Dopaminergic synapse, Non-alcoholic fatty liver disease (NAFLD) |
Active human GSK3 alpha full length protein - ab42597 from Abcam
|
||||||||||
Human GSK3 alpha peptide - ab93065 from Abcam
|
||||||||||
Human GSK3 alpha protein fragment - ab158595 from Abcam
|
||||||||||
GSK3A / GSK3 Alpha Antibody Blocking Peptide - LS-E3642 from LifeSpan Bioscience
|
||||||||||
GSK3A / GSK3 Alpha Antibody Blocking Peptide - LS-E10579 from LifeSpan Bioscience
|
||||||||||
GSK3A / GSK3 Alpha Antibody Blocking Peptide - LS-E9505 from LifeSpan Bioscience
|
||||||||||
GSK-3 alpha Partial Recombinant Protein - H00002931-Q01 from Novus Biologicals
|
||||||||||
GSK-3 alpha Recombinant Protein - P3866 from Novus Biologicals
|
||||||||||
Recombinant Human GSK-3 alpha Protein - P4182 from Novus Biologicals
|
||||||||||
Recombinant Human GSK-3 alpha Protein - NBP1-99200 from Novus Biologicals
|
||||||||||
GSK-3 alpha Peptide - P3121 from Novus Biologicals
|
||||||||||
GSK3A-Antibody-S21-Blocking-peptide - BP8120c from Abgent, a WuXi AppTec company
|
||||||||||
GSK3-alpha-GSK3A-Antibody-C-term-Blocking-peptide - BP8120b from Abgent, a WuXi AppTec company
|
||||||||||
GSK3A; GSK3B peptide - orb219096 from Biorbyt
|
||||||||||
GSK3 alpha protein (GST Fusion) - 80R-2554 from Fitzgerald
|
||||||||||
GSK3A Blocking Peptide - 33R-6426 from Fitzgerald
|
||||||||||
Human GSK3a Protein - abx066875 from Abbexa
|
||||||||||
GSK3 alpha - H00002931-Q01-10 from Acris Antibodies
|
||||||||||
GSK3 alpha - H00002931-Q01-25 from Acris Antibodies
|
||||||||||
GSK3 alpha - P3866 from Acris Antibodies
|
||||||||||
GSK3 alpha - P4182 from Acris Antibodies
|
||||||||||
GSK3A fusion protein - Ag16108 from Proteintech Group
|
||||||||||
GSK3A fusion protein - Ag4168 from Proteintech Group
|
||||||||||
GSK3alpha, Active Human Recombinant Protein - GWB-FCAF97 from Genway Biotech
|
||||||||||
GSK3-alpha (Phospho-Ser21) Antibody Blocking Peptide - GWB-796EC8 from Genway Biotech
|